The historical rank and industry rank for Vivanza Biosciences's OCF Margin % or its related term are showing as below:
BOM:530057'
s OCF Margin % Range Over the Past 10 Years
Min: -59.53 Med: 0.28 Max: 32.36
Current: -2.23
During the past 13 years, the highest OCF Margin % of Vivanza Biosciences was 32.36%. The lowest was -59.53%. And the median was 0.28%.
BOM:530057's OCF Margin % is ranked worse than 75.7% of 963
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs BOM:530057: -2.23
Vivanza Biosciences OCF Margin % Related Terms
Vivanza Biosciences OCF Margin % Historical Data
* Premium members only.
The historical data trend for Vivanza Biosciences's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vivanza Biosciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivanza Biosciences OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vivanza Biosciences's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Vivanza Biosciences's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivanza Biosciences (BOM:530057) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vivanza Biosciences and its competitors. According to the industry distribution chart, Vivanza Biosciences ranks #729 out of 963 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is Vivanza Biosciences' OCF Margin % too high?
Vivanza Biosciences' current OCF Margin % is 0.00%. Based on the distribution chart, Vivanza Biosciences ranks #729 out of 963 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vivanza Biosciences has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vivanza Biosciences' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vivanza Biosciences ranks #729 out of 963 companies for OCF Margin %. This places Vivanza Biosciences in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vivanza Biosciences and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivanza Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivanza Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Vivanza Biosciences (BOM:530057) is currently considered Possible Value Trap. The stock's GF Value™ is ₹26.23, compared to a current price of ₹2.00 — trading 92.4% below its estimated fair value. The current OCF Margin % is 0.00%. Vivanza Biosciences' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vivanza Biosciences (BOM:530057), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vivanza Biosciences (BOM:530057) Overvalued in 2026?
Based on GuruFocus' analysis, Vivanza Biosciences stock appears to be undervalued.
The current stock price of ₹2.00 is trading 92.4% below its estimated GF Value™ of ₹26.23.
GuruFocus considers Vivanza Biosciences to be Possible Value Trap.
Key valuation signals for BOM:530057:
OCF Margin %: 0.00%
GF Value™: ₹26.23 vs. price of ₹2.00 (92.4% below fair value)
No single metric tells the full story. See the BOM:530057 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.
60GF Score
Get the complete analysis for BOM:530057
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530057 has been successfully added to your 
